Here are five points:
1. EIT leverages 3-D printing technology to create spinal implant cages.
2. EIT manufactures Cellular Titanium implants.
3. SHS’ investment pulls from its fourth fund generation.
4. The investment will fund EIT’s international expansion, as well as development of new products.
5. EIT is looking to expand to the United States.
More articles on devices:
Medtronic, Nevro, Boston Scientific & St. Jude Medical lead SCS global market: 4 observations
InVivo enrolls 9th patient in INSPIRE Study: 4 takeaways
Medtronic commits to continued education of young spine surgeons: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
